ON-Q-ITY, INC.

Profile

Company Names

ON-Q-ITY, INC.

Addresses

610 LINCOLN STREET, 3RD FLOOR, NORTH BUILDING, WALTHAM, MA 02451

Phone Numbers

781-895-8100

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$2,500,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2012-02-14 
$2,500,000.00 
$6,533,458.00 
$4,033,458.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRUCE 
 
BOOTH 
DIRECTOR
MIRAGEN THERAPEUTICS INC   |  AVILA THERAPEUTICS INC   |  ZAFGEN, INC.   |  NIMBUS DISCOVERY, LLC   |  ON-Q-ITY, INC.   |  NUMERATE INC   |  UNUM THERAPEUTICS, INC.   |  LYSOSOMAL THERAPEUTICS, INC.   |  AVROBIO, INC.   |  MAGENTA THERAPEUTICS, INC.   |  ATLAS VENTURE FUND XI, L.P.   |  RODIN THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND I, L.P.   |  ATLAS VENTURE FUND XII, L.P.   |  VIGIL NEUROSCIENCE, INC.   |  ATLAS VENTURE OPPORTUNITY FUND II, L.P.   |  ATLAS VENTURE FUND XIII, L.P.   |  MATCHPOINT THERAPEUTICS INC.   |  ATLAS VENTURE FUND XIV, L.P.   |  ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
ROBERT 
S. 
EPSTEIN 
DIRECTOR
ON-Q-ITY, INC.   |  FATE THERAPEUTICS INC   |  DECIPHER BIOSCIENCES, INC.
STEPHEN 
 
KRAUS 
DIRECTOR
STROMEDIX INC   |  VERASTEM, INC.   |  ON-Q-ITY, INC.   |  OVASCIENCE, INC.   |  HEALTH ESSENTIALS HOLDINGS, INC.   |  DOCUTAP, INC.   |  FLEX PHARMA, INC.   |  WELLTOK, INC.   |  ALLENA PHARMACEUTICALS, INC.   |  BRIGHT HEALTH INC.   |  ALCRESTA THERAPEUTICS, INC.   |  ARTEMIS HEALTH INC.   |  MURAL HEALTH TECHNOLOGIES, INC.
DION 
 
MADSEN 
DIRECTOR
ELIXIR PHARMACEUTICALS, INC.   |  HALOSOURCE INC   |  SURFACE LOGIX INC   |  ON-Q-ITY, INC.   |  ZYMEWORKS INC.   |  MILESTONE PHARMACEUTICALS INC.
SUE 
 
SIEGEL 
DIRECTOR
ATTLEE, INC.   |  CRESCENDO BIOSCIENCE, INC.   |  PERSONALIS, INC.   |  ON-Q-ITY, INC.
MICHAEL 
T. 
STOCUM 
EXECUTIVE OFFICER
ON-Q-ITY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-02-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#